Holen Sie sich die Stockscreener-App
3.18
2.73%
-0.12
Schlusskurs vom Vortag:
$3.30
Offen:
$3.29
24-Stunden-Volumen:
98,465
Relative Volume:
0.42
Marktkapitalisierung:
$127.96M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
28.91
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
+1.26%
1M Leistung:
-12.77%
6M Leistung:
+55.83%
1J Leistung:
+37.77%
1-Tages-Spanne:
$3.13
$3.29
1-Wochen-Bereich:
$3.13
$3.36
52-Wochen-Spanne:
$1.82
$3.71
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.215 | 131.35M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.68 | 119.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.42 | 83.75B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
845.74 | 52.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
336.99 | 44.12B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
356.56 | 39.73B | 4.98B | 69.60M | 525.67M | 0.5198 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
Will Oramed Pharmaceuticals Inc. (OJU1) stock recover faster than industryJuly 2025 Gainers & Precise Swing Trade Entry Alerts - mfd.ru
Is Oramed Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Weekly Recap & AI Enhanced Market Trend Forecasts - mfd.ru
Aug Setups: What drives Oramed Pharmaceuticals Inc.’s stock priceJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
What are analysts’ price targets for Oramed Pharmaceuticals Inc.July 2025 Snapshot & Low Risk High Win Rate Picks - mfd.ru
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Short Interest Up 57.8% in January - MarketBeat
Geopolitics Watch: Can Oramed Pharmaceuticals Inc keep up with sector leaders2025 Earnings Surprises & Weekly Top Gainers Trade List - baoquankhu1.vn
Is Oramed Pharmaceuticals Inc. stock undervalued right nowWeekly Gains Report & Safe Capital Investment Plans - mfd.ru
Support Test: Should you avoid Oramed Pharmaceuticals Inc stock right now2025 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Will Oramed Pharmaceuticals Inc. (OJU1) stock test record highs in 2025Weekly Earnings Recap & Reliable Momentum Entry Alerts - mfd.ru
Can Oramed Pharmaceuticals Inc. maintain sales growthJuly 2025 Levels & Real-Time Stock Price Movement Reports - mfd.ru
What drives Oramed Pharmaceuticals Inc.’s stock priceDividend Hike & Accurate Trade Setup Notifications - mfd.ru
What hedge funds are buying Oramed Pharmaceuticals Inc.2025 Winners & Losers & Verified Momentum Stock Alerts - mfd.ru
Aug Outlook: How much upside does Bakkt Holdings Inc Equity Warrant haveRecession Risk & Growth Focused Stock Pick Reports - baoquankhu1.vn
Bull Bear: What is the target price for Oramed Pharmaceuticals Inc. stockSwing Trade & Intraday High Probability Alerts - mfd.ru
NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN
Oramed Pharmaceuticals (NASDAQ:ORMP) & Demant A/S (OTCMKTS:WILYY) Head to Head Analysis - Defense World
Pullback Watch: Is Oramed Pharmaceuticals Inc stock a smart retirement pickQuarterly Profit Report & Daily Technical Forecast Reports - baoquankhu1.vn
What is the next catalyst for Oramed Pharmaceuticals Inc.July 2025 Sentiment & Stock Portfolio Risk Control - mfd.ru
Swing Trade: What is Oramed Pharmaceuticals Incs 5 year growth outlookJuly 2025 Market Mood & Breakout Confirmation Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals Achieves 60.85% Return, Leading Market Performance - Markets Mojo
OraTech to pioneer oral insulin with $75 million investment - MSN
Oramed Pharm completes warrant sale, boosting liquidity - MSN
NNDM Stock In Focus: Nano Dimension Pops A Poison Pill Days After Oramed Stake Build-Up - Stocktwits
Aug Update: What is ReTo Eco Solutions Incs book value per shareJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Jobs Data: Is Oramed Pharmaceuticals Inc stock good for income investors2025 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Oramed Shares Face Pressure Amid Strategic Pivot and Dividend Focus - AD HOC NEWS
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Sees Large Increase in Short Interest - MarketBeat
Published on: 2026-01-17 10:34:33 - baoquankhu1.vn
Oramed Pharmaceuticals Inc.: - marketscreener.com
Oramed Pharm pivots with Lifeward strategic platform deal - TipRanks
Oramed Pharmaceuticals Signs Multiple Material Agreements - TradingView — Track All Markets
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Oramed to transfer oral drug delivery platform to Lifeward By Investing.com - Investing.com Nigeria
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal - Investing.com Nigeria
Buyout Rumor: Can Oramed Pharmaceuticals Inc maintain sales growthQuarterly Investment Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Oramed And Lifeward Reveal Strategic Deal - Pulse 2.0
Oramed to transfer oral drug delivery platform to Lifeward - Investing.com India
Lifeward to acquire Oramed’s oral protein delivery tech in $47 million deal By Investing.com - Investing.com South Africa
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company - manilatimes.net
Oramed and Lifeward Announce Strategic Transaction - Financial Times
Lifeward Ltd. announced that it expects to receive $20 million in funding from Oramed Pharmaceuticals Inc. - marketscreener.com
Oramed Announces Shareholder Capital Return Following Strategic Windfall - AD HOC NEWS
Take Profit: Will Oramed Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Intraday Action & Growth Focused Investment Plans - Улправда
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025Trade Performance Summary & Risk Managed Investment Entry Signals - Улправда
Is Oramed Pharmaceuticals Inc. stock a buy in volatile markets2025 Retail Activity & Daily Volume Surge Signals - ulpravda.ru
Will Oramed Pharmaceuticals Inc. stock outperform value stocks2025 Key Lessons & Intraday High Probability Alerts - ulpravda.ru
Oramed Pharmaceuticals Inc. Declares Dividend of $0.25 (NASDAQ:ORMP) - MarketBeat
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):